Help on the way for overactive bladders

Posted by on 20 Jun 2012 in News | 0 comments

As well as taking part in many prostate cancer studies, Canterbury Urology Research Trust have a long history of experience in trials for people with Overactive Bladder (OAB). OAB is a urological condition defined by a set of symptoms: urgency, frequency, with or without urge incontinence. (Urge incontinence is the involuntary loss of urine due to bladder spasms or contractions.) It can be a common and distressing problem, which may have a profound impact on quality of life.

It is estimated that OAB is prevalent in approximately 16% to 17% of the population world-wide, and therefore is at least as common a disorder as diabetes. As the world population continues to age over time, the prevalence of OAB is only expected to increase.

CURT is currently taking part in an OAB study sponsored by Astellas Pharma

 

If suitable, the subjects can be involved in the study for up to 64weeks. The benefits of taking part in a research study such as this, even if on placebo medication, are considerable. Whilst on study subjects are carefully monitored and have regular visits to medical staff, including Consultant Urologists.